Skip to main content
Launch offer40% off your first paymentEnds 31 DecemberSee plans
Gossamer Bio logo

Gossamer Bio

Biotech & Pharmaceuticals
WebsiteLinkedIn

Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development of its investigational drug product, seralutinib, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Its goal is to enhance the lives of people living with rare diseases.

Open roles
1
Company size
51 - 200 employees
Headquarters
San Diego, California, United States

Follow Gossamer Bio

Create an exact-company alert for on-site matches and optional daily email.

Open roles